CR Pharmaceutical: CR Double-Crane's net profit for the first three quarters is 1.388 billion yuan, a year-on-year decrease of 1.7%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CR Pharmaceutical announced that CR Double-Crane achieved a total operating revenue of 8.283 billion yuan (RMB, the same below) for the nine months ending September 30, 2025, a year-on-year decrease of 3.1%; net profit was 1.388 billion yuan, a year-on-year decrease of 1.7%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments